The PAXgene® Tissue System Preserves Phosphoproteins in Human Tissue Specimens and Enables Comprehensive Protein Biomarker Research

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Gündisch, Sibylle ^a,c   Schott, Christina ^a,c   Wolff, Claudia ^a   Tran, Kai ^a   Beese, Christian ^a   Viertler, Christian ^b,c   Zatloukal, Kurt ^b,c   Becker, Karl Friedrich ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c QIAGEN GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PHOSPHOPROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PRESERVATION AND STORAGE; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TEMPERATURE; TISSUE PRESERVATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEOPLASMS; PARAFFIN EMBEDDING; PHOSPHOPROTEINS; PROTEIN DENATURATION; TEMPERATURE; TISSUE FIXATION; TISSUE PRESERVATION;

EID: 84875517001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060638     Document Type: Article

References (27)

1. Nirmalan NJ, Harnden P, Selby PJ, Banks RE, (2008) Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges. Mol Biosyst 4: 712-720.
2. Tanca A, Pagnozzi D, Addis MF, (2012) Setting proteins free: Progresses and achievements in proteomics of formalin-fixed, paraffin-embedded tissues. Proteomics Clin Appl 6: 7-21.
3. Ralton LD, Murray GI, (2011) The use of formalin fixed wax embedded tissue for proteomic analysis. J Clin Pathol 64: 297-302.
4. National Toxicology Program (2010) Final Report on Carcinogens Background Document for Formaldehyde. Rep Carcinog Backgr Doc: i-512.
5. Evers DL, Fowler CB, Cunningham BR, Mason JT, O'Leary TJ, (2011) The effect of formaldehyde fixation on RNA: optimization of formaldehyde adduct removal. J Mol Diagn 13: 282-288.
6. Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K, (1999) Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 27: 4436-4443.
7. Campos PF, Gilbert TM, (2012) DNA extraction from formalin-fixed material. Methods Mol Biol 840: 81-85.
8. Bussolati G, Annaratone L, Medico E, D'Armento G, Sapino A, (2011) Formalin fixation at low temperature better preserves nucleic acid integrity. PLoS One 6: e21043.
9. Mueller C, Edmiston KH, Carpenter C, Gaffney E, Ryan C, et al. (2011) One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens. PLoS One 6: e23780.
10. Ergin B, Meding S, Langer R, Kap M, Viertler C, et al. (2010) Proteomic analysis of PAXgene-fixed tissues. J Proteome Res 9: 5188-5196.
11. Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, et al. (2011) Histological assessment of PAXgene tissue fixation and stabilization reagents. PLoS One 6: e27704.
12. Viertler C, Groelz D, Gündisch S, Kashofer K, Reischauer B, et al. (2012) A New Technology for Stabilization of Biomolecules in Tissues for Combined Histological and Molecular Analyses. J Mol Diagn. 2012 Jun 28. [Epub ahead of print].
13. Broxterman HJ, Georgopapadakou NH, (2004) New cancer therapeutics: target-specific in, cytotoxics out? Drug Resist Updat 7: 79-87.
14. Wolff C, Schott C, Porschewski P, Reischauer B, Becker KF, (2011) Successful protein extraction from over-fixed and long-term stored formalin-fixed tissues. PLoS One 6: e16353.
15. Becker KF, Schott C, Hipp S, Metzger V, Porschewski P, et al. (2007) Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol 211: 370-378.
16. Xie R, Chung JY, Ylaya K, Williams RL, Guerrero N, et al. (2011) Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem 59: 356-365.
17. Braun M, Menon R, Nikolov P, Kirsten R, Petersen K, et al. (2011) The HOPE fixation technique--a promising alternative to common prostate cancer biobanking approaches. BMC Cancer 11: 511.
18. Dotti I, Bonin S, Basili G, Nardon E, Balani A, et al. (2010) Effects of formalin, methacarn, and fineFIX fixatives on RNA preservation. Diagn Mol Pathol 19: 112-122.
19. Lassalle S, Hofman V, Marius I, Gavric-Tanga V, Brest P, et al. (2009) Assessment of morphology, antigenicity, and nucleic acid integrity for diagnostic thyroid pathology using formalin substitute fixatives. Thyroid 19: 1239-1248.
20. Stanta G, Mucelli SP, Petrera F, Bonin S, Bussolati G, (2006) A novel fixative improves opportunities of nucleic acids and proteomic analysis in human archive's tissues. Diagn Mol Pathol 15: 115-123.
21. Ostasiewicz P, Zielinska DF, Mann M, Wisniewski JR, (2010) Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J Proteome Res 9: 3688-3700.
22. Addis MF, Tanca A, Pagnozzi D, Rocca S, Uzzau S, (2009) 2-D PAGE and MS analysis of proteins from formalin-fixed, paraffin-embedded tissues. Proteomics 9: 4329-4339.
23. Tanca A, Pagnozzi D, Falchi G, Tonelli R, Rocca S, et al. (2011) Application of 2-D DIGE to formalin-fixed, paraffin-embedded tissues. Proteomics 11: 1005-1011.
24. Bergh GV, (2009) Two-dimensional difference gel electrophoresis. Methods Mol Biol 519: 439-454.
25. Minden JS, Dowd SR, Meyer HE, Stuhler K, (2009) Difference gel electrophoresis. Electrophoresis 30Suppl 1: S156-161.
26. Jin H, Zangar RC, (2010) Antibody microarrays for high-throughput, multianalyte analysis. Cancer Biomark 6: 281-290.
27. Zangar RC, Daly DS, White AM, (2006) ELISA microarray technology as a high-throughput system for cancer biomarker validation. Expert Rev Proteomics 3: 37-44.